Ep170: David Schenkein on Investing in the Future of Biotech
The Long Run with Luke Timmerman
Transitioning from CEO to Venture Capitalist in Biotech
This chapter explores the transition of a former healthcare CEO to a venture capitalist, detailing their successful track record in biotech. The discussion highlights their motivations for joining GV and their aspirations to make a significant impact in science and medicine.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
